TactiFlex Ablation Catheter SE (A-TFSE-D, A-TFSE-F, A-TFSE-J, A-TFSE-DD, A-TFSE-DF, A-TFSE-FF, A-TFSE-FJ, A-TFSE-JJ, A-T
ABBOTT MEDICAL · Decision date Feb 3, 2026
What did the FDA decide?
FDA records P220013/S027 as a supplement to PMA P220013, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Feb 3, 2026.
FDA approval order statement
a manufacturing equipment parameter change for the electrode swaging machines
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Feb 3, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P220013/S027
- Regulatory pathway
- PMA supplement
- Applicant
- ABBOTT MEDICAL
- Product code
- OAE
- Decision code
- OK30
- Decision date
- Feb 3, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation.
- Applicant
- Abbott Medical
- Product code
- OAE
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P220013. Subsequent supplements may change the device or its indications.
FDA decision timeline
P220013 · Original PMA
TactiFlex Ablation Catheter, Sensor Enabled, TactiSys Quartz Equipment, TactiSys Quartz, TactiFlex Radiofrequency C
P220013/S020 · Related supplement
TactiFlex Ablation Catheter, Sensor Enabled
P220013/S021 · Related supplement
TactiFlex Ablation Catheter, Sensor Enabled
P220013/S023 · Related supplement
TactiFlex Ablation Catheter, Sensor Enabled (TactiFlex SE)
P220013/S025 · Related supplement
TactiFlex Ablation Catheter, Sensor Enabled (TactiFlex SE)
P220013/S027 received
Application receipt date recorded by FDA.
P220013/S026 · Related supplement
TactiFlex Sensor Enabled
P220013/S027 · FDA decision
30-Day Notice
P220013/S029 · Related supplement
TactiFlex Ablation Catheter, Sensor Enabled (A-TFSE-D; A-TFSE-F; A-TFSE-J; A-TFSE-DD; A-TFSE-DF; A-TFSE-FF; A-TFSE-FJ;
P220013/S022 · Related supplement
TactiFlex Sensor Enabled Ablation Catheter
P220013/S032 · Related supplement
TactiFlex Ablation Catheter, Sensor Enabled (TactiFlex SE)
P220013/S031 · Related supplement
TactiFlex Ablation Catheter, Sensor Enabled
P220013/S030 · Related supplement
TactiFlex Ablation Catheter, Sensor Enabled, TactiSys Quartz Equipment, TactiSys Quartz, TactiFlex Radiofrequency C
P220013/S033 · Related supplement
TactiSys Quartz Equipment; Ampere Generator
P220013/S028 · Related supplement
TactiFlex Duo Ablation Catheter, Sensor Enabled (A-TFDM-D, A-TFDM-F, A-TFDM-J, A-TFDM-DD, A-TFDM-DF, A-TFDM-FF, A-TFDM
P220013/S034 · Related supplement
TactiFlex Ablation Catheter, Sensor Enabled
Timeline entries are records held by MedtechLedger for P220013. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P220013
Explore the linked device profile
Other records with product code OAE
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
STOP Persistent AFP100010/S154 | Medtronic Cryocath, LP | PMA supplement | Sep 25, 2026 | FDA |
| Biosense Webster, Inc. | PMA supplement | Sep 15, 2026 | FDA | |
QDOT MICRO SystemP210027/S018 | Biosense Webster, Inc. | PMA supplement | Sep 10, 2026 | FDA |
TX eco CableP210027/S017 | Biosense Webster, Inc. | PMA supplement | Aug 17, 2026 | FDA |
TactiSys Quartz Equipment; Ampere GeneratorP130026/S102 | St Jude Medical | PMA supplement | Aug 7, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 5050 Nathan Ln. N., Plymouth, MN, 55442
Sources and methodology
- Original FDA record: P220013/S027
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



